Granules India Ltd (GRANULES) — shareholding pattern, promoter holding, financials and share price
About Granules India Ltd (GRANULES)
Granules India Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as GRANULES and on the BSE under scrip code 532482. Its ISIN is INE101D01020.
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. [1]
Granules India Limited is a vertically integrated pharmaceutical company specializing in Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediates (PFI), and Finished Dosage (FD). Known for its leadership in off-patent drugs, it serves global branded and generic pharma firms with core products like Paracetamol and Ibuprofen.
In Q3 FY26, Granules India reported a 22% year-over-year revenue growth, driven mainly by the Finished Dosage segment in North America and Europe. Their EBITDA also saw a meaningful jump of 34% year-over-year, signifying improved operating leverage.
Listed peers in Pharmaceuticals: Rubicon Research Ltd, Piramal Pharma Ltd, Pfizer Ltd, Astrazeneca Pharma India Ltd, ERIS Lifesciences Ltd, Caplin Point Laboratories Ltd.
Valuation & Returns
10 Jul 2026At ₹890 a share on 10 Jul 2026, Granules India Ltd (GRANULES) was valued at a price-to-earnings ratio of 37.06x against an industry P/E of 36.41x and a price-to-book of 5.94x on a book value of ₹149.94 per share as of Mar 2025. Solomo computes return on equity of 16.01% and return on capital employed of 17.39% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 37.06x
- Industry P/E
- 36.41x
- P/B
- 5.94x
- EPS (TTM)
- ₹24.01
- Book value / share
- ₹149.94
- ROE
- 16.01%
- ROCE
- 17.39%
- ROA
- 9.52%
- Debt / equity
- 0.39x
- Dividend yield
- 0.17%
- EBITDA margin
- 22.39%
- 52-week range
- ₹433 – ₹901.1
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Granules India Ltd (GRANULES) reported revenue of ₹5,366 crore, net profit of ₹595 crore and earnings per share of ₹24.01. That compares with revenue of ₹4,482 crore and net profit of ₹502 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹1,471 crore and net profit ₹202 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 3,765 | 4,512 | 4,506 | 4,482 | 5,366 |
| Net profit (₹ cr) | 413 | 517 | 405 | 502 | 595 |
| EPS (₹) | 16.64 | 21.34 | 16.72 | 20.68 | 24.01 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 9.37% | 5.58% | -2.19% | -0.55% |
| Profit growth | 11.41% | -6.38% | -6.17% | 23.74% |
| Stock price CAGR | 20% | 19% | 43% | 81% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 38.02% of Granules India Ltd (GRANULES) (unchanged from the previous quarter), foreign institutional investors (FII) hold 17.5% and domestic institutional investors (DII) hold 16.11%. Market capitalisation was ₹22,054 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2002.
Largest disclosed public shareholders in Jun 2026: LIFE INSURANCE CORPORATION OF INDIA 4.1%, SBI LIFE INSURANCE CO. LTD 2.84%, KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD. 1.7%, SMALLCAP WORLD FUND, INC 1.59%, ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C 1.43%, BASAVA SANKARA RAO KOLLI 1.17%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 38.02% | - | 17.5% | 16.11% | 61.98% |
| Mar 2026 | 38.02% | - | 15.31% | 17.01% | 61.98% |
| Dec 2025 | 38.82% | - | 13.55% | 17.48% | 61.18% |
| Sep 2025 | 38.82% | - | 14.09% | 17.92% | 61.18% |
| Jun 2025 | 38.82% | - | 13.24% | 23.53% | 61.18% |
| Mar 2025 | 38.84% | - | 15.15% | 22.45% | 61.16% |
| Dec 2024 | 38.85% | - | 15.87% | 19.57% | 61.15% |
| Sep 2024 | 38.87% | - | 19.49% | 14.87% | 61.13% |